| http://www.w3.org/ns/prov#value | - Age is the biggest risk factor for these diseases, and with an aging population, the need for greater understanding and better treatments is urgent, said Todd Sherer, Ph.D., CEO of MJFF. We hope that through cross-disease analysis, we will uncover shared pathways or convergences, which could lead to therapies that could help patients across the continuum of neurodegeneration.
|
